Presentation TCT 2017 Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS? Presenter: Samir R. Kapadia, Ioanna Kosmidou November 01, 2017
Presentation TCT 2017 Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure? Presenter: Samir R. Kapadia, David J. Moliterno November 01, 2017
Presentation TCT 2017 Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping Presenter: Samir R. Kapadia, Sameer Gafoor November 01, 2017
Presentation TCT 2017 Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset Presenter: Samir R. Kapadia, Brian K. Whisenant November 01, 2017
Presentation TCT 2017 Rationale and Potential Role for LAA Closure in the PCI and ACS Patient Presenter: Samir R. Kapadia, Ashish Pershad November 01, 2017
Presentation TCT 2017 Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy Presenter: Thomas H. Maloney, C. Michael Gibson October 30, 2017
Presentation Fellows 2017 How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy Presenter: Manish A. Parikh, David J. Cohen April 07, 2017
Presentation CRT 2017 Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement Presenter: Chadi Alraies February 22, 2017